These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38019119)

  • 1.
    Zhu M; Chen X; Hao Z; He Y; Han B; Tang S
    Pharmacogenomics; 2023 Dec; 24(18):931-942. PubMed ID: 38019119
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.
    Sun Q; Liu HP; Zheng RJ; Wang P; Liu ZB; Sha W; Xiao HP
    Clin Drug Investig; 2017 Dec; 37(12):1125-1136. PubMed ID: 28900877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Chen R; Wang J; Tang S; Zhang Y; Lv X; Wu S; Xia Y; Deng P; Ma Y; Tu D; Chen D; Zhan S
    Tuberculosis (Edinb); 2015 Jan; 95(1):68-74. PubMed ID: 25498879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
    Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
    Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.
    Yang M; Qiu Y; Jin Y; Liu W; Wang Q; Yi H; Tang S
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00696. PubMed ID: 33300686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies.
    Wang FJ; Wang Y; Niu T; Lu WX; Sandford AJ; He JQ
    J Clin Pharm Ther; 2016 Jun; 41(3):334-40. PubMed ID: 27062377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis.
    Han JM; Choi KH; Lee HH; Gwak HS
    Anticancer Drugs; 2022 Jan; 33(1):75-79. PubMed ID: 34726639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population.
    Lu L; Tao B; Wei H; Chen H; He X; Pan H; Yang M; Yi H; Tang S
    J Gene Med; 2019 Jun; 21(6):e3096. PubMed ID: 31066138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
    Tang SW; Lv XZ; Zhang Y; Wu SS; Yang ZR; Xia YY; Tu DH; Deng PY; Ma Y; Chen DF; Zhan SY
    J Clin Pharm Ther; 2012 Oct; 37(5):588-93. PubMed ID: 22335459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis.
    Du H; Chen X; Fang Y; Yan O; Xu H; Li L; Li W; Huang W
    Mol Biol Rep; 2013 May; 40(5):3591-6. PubMed ID: 23277397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
    Wang Y; Xiang X; Wu SQ; Chen G; Zhang MM; Wang MG; Wang FJ; Sandford AJ; He JQ
    Infect Genet Evol; 2017 Jul; 51():198-202. PubMed ID: 28389387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.
    Wang J; Chen R; Tang S; Lv X; Wu S; Zhang Y; Yang Z; Xia Y; Chen D; Zhan S
    J Clin Pharm Ther; 2015 Apr; 40(2):186-91. PubMed ID: 25308608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity.
    Wang Y; Xiang X; Huang WW; Sandford AJ; Wu SQ; Zhang MM; Wang MG; Chen G; He JQ
    Sci Rep; 2019 Feb; 9(1):2217. PubMed ID: 30778091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.
    Chen X; Hao Z; Pan H; Liu W; Lu L; Zhang M; He X; Yi H; Tang S
    Fundam Clin Pharmacol; 2023 Aug; 37(4):858-867. PubMed ID: 36855016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury.
    Jin S; Li X; Fan Y; Fan X; Dai Y; Lin H; Cai W; Yang J; Xiang X
    Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):508-517. PubMed ID: 31240859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.
    Yang M; Pan H; Chen H; Liu W; Lu L; He X; Yi H; Tang S
    Infect Genet Evol; 2020 Sep; 83():104349. PubMed ID: 32387752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population.
    Pan H; Yang M; Lu L; Tao B; He X; Chen H; Yi H; Tang S
    Pharmacogenet Genomics; 2019 Jun; 29(4):84-90. PubMed ID: 30720667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of the nuclear factor erythroid 2-related factor 2/antioxidant reaction element pathway on the risk of antituberculosis drug-induced liver injury: a systematic review.
    Hao Z; Zhang M; Chen X; Zhu M; Han B; He Y; Yi H; Tang S
    Pharmacogenomics; 2023 Apr; 24(6):345-357. PubMed ID: 37166414
    [No Abstract]   [Full Text] [Related]  

  • 20. The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Zhang H; Qian H; Tao B; Yang M; Gong J; Yi H; Tang S
    Infect Genet Evol; 2018 Dec; 66():217-221. PubMed ID: 30316884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.